Min.Order / FOB Price:Get Latest Price
1 Kilogram |
FOB Price: USD 1.0000 |
competitive price 86050-77-3 steady quality Gadopentetate Dimeglumine low price 86050-77-3
Low price steady quality Gadopentetate Dimeglumine 86050-77-3
Jinan Hongfangde Pharmatech Co., Ltd.is a company combined with development, production, sale and international trading. It possesses of a laboratorial building for new medicine development, perfect experimental instruments and a group of experienced senior technical engineers and talented administrant. Its business is mainly for the development, production, sale and export on APIs, chemicals and intermediates. At present, company has already established a good business relationship with Japanese. Aiming at “enterprise internationalizing”, Jinan Hongfangde Pharmatech Co., Ltd. bases upon both domestic and international markets, is looking for the future market demand of globe, and welcoming national friends’ visit for business negotiation, to go ahead hand to hand and develop multi-item cooperation.
Low price steady quality Gadopentetate Dimeglumine 86050-77-3
Overview:
Pro Name | Gadopentetate dimeglumine |
CAS No | 86050-77-3 |
Synonyms |
2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate,gadolinium(3+),(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;
Meglumine gadopentetate;
|
Formula | C28H54GdN5O20 |
Exact Mass | 938.26000 |
Molecular Weight | 938.00000 |
PSA | 431.07000 |
LogP |
-12.62350 |
Gadopentetic acid is one of the trade names for a gadolinium -basedMRI contrast agent, usually administered as a salt of a complex of gadolinium with DTPA (diethylenetriaminepentacetate ) with the chemical formula A2[Gd(DTPA)(H2O)]; when cation A is the protonated form of theamino sugar meglumine the salt goes under the name "Gadopentetate dimeglumine". It was described in 1981 and introduced as the first MRI contrast agent in 1987. It is used to assist imaging of blood vessels and of inflamed or diseased tissue where the blood vessels become 'leaky'. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood–brain barrier. It is usually injected intravenously. Gd-DTPA is classed as an acyclic, ionic gadolinium contrast medium. Its paramagnetic property reduces the T1relaxation time (and to some extent the T2 and T2* relaxation times) inNMR, which is the source of its clinical utility.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View